The European Medicines Agency is seeking to help developers of investigational drugs that have been accepted onto its PRIME (priority medicines) scheme to maximize their chances of quickly developing and winning marketing approval for their products.
Experience to date has shown that developers face difficulties when it comes to preparing robust quality data packages for their...








